Skip to Main Content

Search in Medi-Cal

The search's minimum of 4 and maximum of 60 characters. To search for information outside the provider manual or to find a specific provider communication by the assigned material number, use the search bar located at the top right corner of this page.

Please wait while we retrive the findings...

Search Results for:

Displaying 0 of 0 results...

Prior Authorization Requirements

California
Medi-Cal LA-DHS PPGs

Effective August 1, 2024

The services, procedures, equipment and outpatient pharmaceuticals below apply to:

  • Medi-Cal Los Angeles County Department of Health Services (LA-DHS) participating physician groups (PPGs)

These are subject to prior authorization (PA) requirements (unless noted as “notification” required only) and guaranteed only as of the time of access to this prior authorization requirements page.

Member questions – If members have questions regarding the PA list or requirements, refer to the member services number listed on their identification card.

Medical necessity – Medical necessity must exist for any plan benefit to be a covered service whether a PA is required or not.

Eligibility rules and limitations Providers are responsible for verifying member eligibility through the Health Net Medi-Cal Provider Services Center prior to providing care. Even if a service or supply is authorized, eligibility rules and benefit limitations will still apply – all services, procedures, equipment, and outpatient pharmaceuticals are subject to benefit plan coverage limitations.

Submit a PA request –

PA timelines –

If the request is for …

Submit prior authorization request:

An elective in patient or outpatient services or procedures.

As soon as the need for service is identified.

A routine request or procedure.

At least five business days before a scheduled procedure.

An urgent request or procedure.

72 hours before a scheduled procedure. Emergency services do not require prior authorization.

Providers should also refer to Limitations and Exclusions, in addition to Sensitive, Confidential or Other Services that do not require PA for Medi-Cal members at the end of this requirements list.

Inpatient Services

Submit a prior authorization request to Health Net unless stated differently in requirements listed below.

Inpatient Services 1

Hospitalization - Elective

Elective medical or surgical admissions to non-LA-DHS hospitals 2

Includes:

  • Acute care facilities
  • Acute or sub-acute rehabilitation

Hospitalization - Emergency

Notification required only

Emergency hospitalizations and continuing stays at non-LA-DHS hospitals once emergency stabilization is complete

Contact the Health Net Hospital Notification Unit

Long-term care nursing facility admission

Skilled nursing facility (SNF)

All elective admissions to skilled nursing facilities

1Medically necessary procedures performed during acute inpatient hospitalization are included under the inpatient PA (excluding experimental and investigational procedures). Medically necessary procedures performed in emergency situations do not require PA.

2Non-LA-DHS hospitals include hospitals and clinics in Antelope Valley.

Outpatient Procedures, Services or Equipment

Submit a prior authorization request to Health Net unless stated differently in requirements listed below.

OUTPATIENT PROCEDURES, SERVICES OR EQUIPMENT

All referrals to out-of-network providers (non-LA-DHS clinics or hospitals)

PA not required for self-referred services allowed under the Medi-Cal plan for family planning, pregnancy termination, HIV counseling and testing, immunizations at the local health department (LHD), and sexually transmitted infections (STIs)

Acupuncture

Behavioral health (outpatient services)

Bronchial thermoplasty

Dental anesthesia: Intravenous (IV) moderate sedation and deep sedation/general anesthesia

Authorized by the Health Net when provided outside of an LA-DHS facility

Durable medical equipment (DME) – Pediatric

Members under age 21: All DME requires PA

DME – Adult

Members ages 21 and older: The following DME requires PA:

  • Bone growth stimulators
  • BiLevel positive airway pressure (BiPAP)
  • Continuous glucose monitoring
  • Continuous positive airway pressure (CPAP)
  • Custom-made items (including orthotics)
  • Hospital beds and mattresses
  • Items with a total Medi-Cal purchase price greater than $1,500
  • Oxygen
  • Power wheelchairs and scooters
  • Ventilators

Enteral nutrition products

Gender reassignment services (transgender services)

Authorized by the Health Net when provided outside of an LA-DHS facility

Genetic testing

Leg stent bridge

Neuro and spinal cord stimulators, including procedures

Authorized by the Health Net when provided outside of an LA-DHS facility

Custom orthotics

Palliative care

Proprietary laboratory analyses

Includes the following CPT®: 0457U, 0459U, 0462U, 0468U, 0472U

Prosthetics

Transplant

  • Fax request to the Transplant Team
  • Transplant evaluations and procedures, including, but not limited to, evaluation, transplant consult visits, donor search, and transplant procedure

Transportation

All non-emergency medical transportation (NEMT) requires a Physician Certification Statement (PCS)

  • Air transportation (air ambulance), authorized by Health Net
  • Ground NEMT, contact Modivcare ambulance, gurney/stretcher, wheelchair)

Outpatient Pharmaceuticals (Submitted Under Medical Benefit)

Medications

OUTPATIENT PHARMACEUTICALS (Submitted Under Medical Benefit)

Medications newly approved by the U.S. Food and Drug Administration (FDA)

May require prior authorization – Contact Health Net Pharmacy Services to confirm

Self-injectables

  • Self-injectable medications are the responsibility of the Medi-Cal Rx Program effective 1/2/22
  • Refer to the Contract Drug List (CDL) on the DHCS website for the Medi-Cal Rx list of covered drugs and services. PA may be required, and providers may use Cover My Meds to submit a PA request or complete a Prior Authorization Form and fax it to 800-859-4325
  • PA required from Health Net for self-injectable medications administered in a physician's office

Testosterone therapy

Outpatient Pharmaceuticals (Submitted Under Medical Benefit)

DRUG/THERAPY CLASS

Gene therapy, includes CAR-T therapy

Examples include:

  • Abecma®*, Adstiladrin®, Breyanzi®*, Carvykti®*, ElevidysTM, Hemgenix®, KymriahTM*, LuxturnaTM, RoctavianTM, Skysona®, TecartusTM*, YescartaTM*, Zynteglo®, Zolgensma®

    *CAR-T therapy

GnRH agonists

Examples include:

  • Camcevi®, Eligard®, Fensolvi®, Lupron Depot®, Lupron Depot-Ped®, Supprelin® LA, Triptodur®, Zoladex®

Authorization required for non-oncology/non-urology only:

  • Eligard®, Lupron Depot, Zoladex®

Hereditary angioedema (HAE) agents

Examples include:

  • Berinert®, Cinryze®, Firazyr®, Haegarda®, Kalbitor®, Ruconest®, Takhzyro®
  • Preferred: Firazyr and Haegarda. See self-injectables
Intravenous (IV) iron agents

Examples include:

  • Injectafer®, Monoferric®, Triferic®/Triferic AVNU

Immune globulin agents

Examples include:

  • Intravenous immunoglobulin (IVIG),  Asceniv®, Bivigam®, Cutaquig®, Cuvitru®, Flebogamma® DIF, GamaSTAN®, GamaSTAN® S/D, Gammagard® Liquid, Gammagard® S/D, GammakedTM, Gammaplex®, Gamunex®-C, Hizentra®, HyQvia®, Octagam®, Panzyga®, Privigen®, Xembify®
  • Preferred: Gammagard

Lysosomal storage disorders

Examples include:

  • Aldurazyme®, Brineura™, Cerezyme®, Elaprase®, Elelyso®, Elfabrio®, Fabrazyme®, Kanuma®, Lamzede®, Lumizyme®,  MepseviiTM,  Naglazyme®, Nexviazyme®, PombilitiTM, Vimizim®, Vpriv®, Xenpozyme®
Pemetrexed agents

Examples include:

  • Alimta® (no PA for generic), Pemfexy TM, Pemrydi RTU®, and other generic
Pulmonary arterial hypertension (PAH) agents

Examples include:

  • PDE-5 inhibitors: Revatio®
  • Prostacylin analogues/receptor agonist injection: Flolan®, Remodulin®, Uptravi®, Veletri®
  • Prostacylin analogues (PCA) inhalation: Tyvaso®, Ventavis®

Ranibizumab agents

Examples include:

  • ByoovizTM, CimerliTM, Lucentis®, Susvimo™
Tobramycin (inhaled) agents

Examples include:

  • Bethkis®, Katabis®, TOBI ® (ages 0-20 only)

Viscosupplementation agents

Examples include:

  • Euflexxa®, Gelsyn-3TM, GenVisc® 850, Hyalgan®, Supartz FXTM, Synojoynt TM, Triluron TM, TriVisc TM, VISCO-3TM, Durolane®, Gel-One®, Hymovis®, Monovisc®, Orthovisc® Synvisc®, Synvisc One®
  • Preferred: Euflexxa, Monovisc, Orthovisc, Synvisc and Synvisc One
  • The following medications require prior authorization from the Health Net Pharmacy Services when provided outside of LA-DHS facility

    For the reference product, all generics or biosimilar drugs will require a prior authorization

Outpatient Pharmaceuticals (Submitted Under Medical Benefit)

Abrilada™

Actemra®

Adakveo®

Adcetris®

Adzynma™

Akynzeo®

Aliqopa™

Amondys 45™

Amvuttra®

Aphexda®

Aralast®

Arzerra®

Asparlas™

Azedra®

Bavencio®

BCG Intravesical

Beleodaq®

Benlysta®

Beovu®

Besponsa®

Blincyto®

Botox®

Briumvi®

Cablivi®

Casgevy™

Ceprotin® (ages 0–20 only)

Cimzia®

Cinqair®

Columvi™

Cortrophin®

Cosela™

Cosentyx®

Crysvita®

Cyramza®

Danyelza®

Darzalex®

Daxxify®

DDAVP® (ages 0–20 only)

Dupixent®

Durysta™

Dysport®

 

 

Elahere™

Elrexfio™

Elzonris®

Empaveli™

Empliciti®

Enjaymo™

Entyvio™

Epkinly™

Erbitux®

Erwinaze® (ages 0–20 only)

Evenity®

Evkeeza™

Exondys 51™

Eylea®/Eylea HD

Fasenra™

Faslodex®

Folotyn®

Fyarro™

Gamifant®

Givlaari

Glassia™

H.P. Acthar® Gel

Halaven®

iDose® TR (implant)

Ilumya®

Ilaris®

Iluvien®

Imfinzi®

Imjudo®

Izervay™

Jelmyto™

Jemperli®

Jesduvroq™

Jevtana®

Keytruda®

Kimmtrak®

Krystexxa®

Kyprolis®

Lemtrada®

Leqembi™

Leqvio®

Levoleucovorin (Fusilev®, Khapzory™)

Libtayo®

Loqtorzi™

Lumoxiti®

Lunsumio™

Lutathera®

Lyfgenia™

Macugen®

Margenza™

Marqibo®

Monjuvi®

Mozobil®

Mylotarg™

Myobloc®

Myozyme®

Novantrone®

Nplate®

Nucala

Nulibry™

Nuzyra®

Ocrevus™

Omvoh™

Oncaspar®

Onpattro™

Opdivo®

Opdualag™

Orencia®

Oxlumo™

Ozurdex®

Padcev®

Panhematin®

Parsabiv®

Pepaxto®

Perjeta®

Phesgo®

Polivy™

Poteligeo®

Prevymis™

Prolastin®

Prolia®

 

Provenge®

Qalsody™

Radicava™

Radiesse®

Reblozyl®

Rebyota™

Reclast®

Retisert®

Revcovi™

Rybrevant™

Rylaze™

Ryplazim®

Rystiggo®

Sandostatin® LAR kit

Saphnelo™

Sarclisa®

Scenesse®

Sculptra®

Sensipar®

Signifor® LAR

Simponi Aria®

Sinuva®

Skyrizi®

Soliris®

Somatuline® Depot

Sotradecol®

Spevigo®

Spinraza™

SpravatoTM

Stelara®

Sustol®

Syfovre™

Synagis®

Synribo®

Talvey™

Tecentriq®

Tecvayli™

Tepezza®

Testopel®

 

Tezspire®

Tivdak™

Tofidence™

Trodelvy®

Tyruko®

Tysabri®

Tzield™

Ultomiris™

Unituxin®

Uplizna®

Vabysmo®

Valstar®

Vectibix®

Velcade® (ages 0–20 only)

Veopoz™

Vidaza®

Viltepso®

Visudyne®

Vyepti™

Vyjuvek®

Vyondys 53®

Vyvgart®

Vyvgart Hytrulo

Vyxeos (ages 0-20 only)

Wezlana™

Xeomin®

Xgeva®

Xiaflex®

Xipere®

Xolair®

Yervoy®

Yutiq™

Zaltrap®

Zemaira®

Zemdri™

Zepzelca™

Zilretta™

Zinplava™

Zulresso™

Zynlonta®

Zynyz®

  • Biosimilars require prior authorization
  • Preferred biosimilars are required in lieu of branded drugs
  • Authorized by Health Net Pharmacy Services
  • Must try preferred products prior to non preferred approval. Please refer to the drug specific policy for complete list of preferred products
OUTPATIENT PHARMACEUTICALS - BIOSIMILARS

NON-PREFERRED

PREFERRED

Bevacizumab agents – Alymsys®, Avastin®, Vegzelma ® (no longer requires PA for ophthalmologists)

Mvasi®, ZirabevTM (no PA required for ophthalmologists)

Erythropoiesis-stimulating agents (ESA) –Aranesp®, Epogen®, Mircera®, Procrit®

RetacritTM (PA not required for Retacrit when administered/provided under the medical benefit)

Filgrastim agents – Granix®, Neupogen®, Releuko®

  • Nivestym®
  • Zarxio® (PA not required for Zarxio when administered/provided under the medical benefit)

Infliximab agents – Remicade®

Avsola®, Inflectra®, Renflexis®

Pegfilgrastim agents – Fulphila®, Fylnetra®, Neulasta®, Neulasta OnPro®, Nyvepria®, RolvedonTM, RyzneutaTM, Stimufend®

Udenyca®, Udenyca Onbody, Ziextenzo®

Rituximab agents – Riabni®, Rituxan®, Rituxan HycelaTM

Ruxience®, Truxima® (no PA required for hematology/oncology indications)

Trastuzumab agents – Enhertu®, Herceptin®, Herceptin HylectaTM, Herzuma®, Kadcyla®, Ontruzant®

Kanjinti®, Ogivri®, TrazimeraTM

Non-Benefit Services Requiring Authorization

Submit a prior authorization request to Health Net

NON-BENEFIT SERVICE

Community Supports

  • Asthma remediation
  • Community transition services/nursing facility transition services to a home
  • Day habilitation
  • Environmental accessibility adaptations (home modifications)
  • Housing deposits
  • Housing tenancy and sustaining services
  • Housing transition navigation 
  • Meals/medically tailored meals
  • Nursing facility transition/diversion to assisted living facilities
  • Personal care and homemaker services
  • Recuperative care (medical respite)
  • Respite services
  • Short-term post-hospitalization housing

Limitations and Exclusions

  • CCS eligible conditions are carve-out services not covered by Health Net and require prior authorization from the local CCS office.
  • CCS services must be provided by CCS-paneled providers and at CCS approved facilities.
  • Any services related to CCS -eligible medical conditions must be approved by the CCS program. Refer to the California Code of Regulations, Title 22, Division 2, Part 2, Subdivision 7, CCS, Chapter 4, Medical Eligibility, Article 4, available online at www.calregs.com.
  • Routine laboratory and radiology services must be performed at a Health Net participating facility.
  • Non-emergency medical transport (NEMT), ground, for medically necessary outpatient services is available upon request by a provider or member who contacts Modivcare. All NEMT require a PCS.
  • Specialty mental health services and select substance use disorder services are covered by the county mental health program. If coordination assistance with the county mental health program is needed, contact Health Net Medi-Cal Member Services.
  • Emergency room (ER) services after stabilization of an emergency medical condition or when the medical screening exam (MSE) does not demonstrate an emergency medical condition are subject to review by Health Net and may not be paid.
  • Cosmetic surgery is not a benefit of the Medi-Cal program. Cosmetic surgery requests are reviewed for possible reconstructive benefits, as well as medical necessity, using the Department of Health Care Services (DHCS) definition of cosmetic surgery.

Sensitive, Confidential or Other Services

Below are sensitive, confidential and other services that do not require PA for Medi-Cal members.

  • Referral or PA is not required for the following sensitive services, and members may obtain them from any qualified in- network or out-of-network provider:
    • Minor consent services – those covered services of a sensitive nature that minors do not need parental consent to access or obtain. Such services are those related to sexual assault, including rape; drug or alcohol abuse (for children ages 12 and older); family planning services; pregnancy, including pregnancy termination; HIV counseling and testing; sexually transmitted infection (STI) diagnosis and treatment (for children ages 12 and older); and outpatient mental health services.
    • Therapeutic and elective pregnancy termination.
  • Family planning, STI diagnosis and treatment, HIV testing and counseling, and sexual assault services.
  • Referral or PA is not required for Comprehensive Perinatal Services Program (CPSP) services. Services may be obtained from any participating CPSP providers. Refer to the https://www.cdph.ca.gov/Programs/CFH/DMCAH/CPSP/Pages/default.aspx CPSP website
  • Other services not requiring PA:
    • Pregnancy care with a participating network obstetrician.
    • Preventive services from a participating provider.
    • Services for emergency medical conditions.
    • Specialist referral (initial referral to participating specialist).
    • Urgently needed services when the member is outside of his or her county. 
    • Certified nurse midwife and obstetrical/gynecological (OB/GYN) services from a participating provider do not require PA. 
    • MOA 638 Indian Health Service facilities
    • Biomarker testing for an insured with advanced or metastatic stage 3 or 4 cancer (FDA approved)
    • COVID-19 diagnostic and screening testing
Last Updated: 11/19/2024